Weiwei Wu
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- interferon and immune responses
- T-cell and B-cell Immunology
- Phagocytosis and Immune Regulation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lymphatic System and Diseases
Papers in
- Immunology 17
- Immunotherapy and Immune Responses 4
- Phagocytosis and Immune Regulation 4
- Oncology 12
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Monica Manglani (1 shared paper)Philipp A. Lang (1 shared paper)Luca Gattinoni (1 shared paper)Yun Ji (1 shared paper)Pamela L. Schwartzberg (1 shared paper)Abdel G. Elkahloun (1 shared paper)Stacie M. Anderson (1 shared paper)Tuoqi Wu (1 shared paper)
- Journals
- Oncotarget (3 papers)Molecular Cancer Therapeutics (2 papers)Blood (2 papers)Cancer Immunology Immunotherapy (2 papers)Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Weiwei Wu
30 papers receiving 1.6k citations
Weiwei Wu's Hit Papers
Peers
Comparison fields: 5 of 92
- Immunology 797
- Oncology 710
- Biological Psychiatry 41
- Behavioral Neuroscience 33
- Molecular Biology 442
Countries citing papers authored by Weiwei Wu
This map shows the geographic impact of Weiwei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Wu more than expected).
Fields of papers citing papers by Weiwei Wu
This network shows the impact of papers produced by Weiwei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Wu. The network helps show where Weiwei Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness Hit paper breakdown → | 2016 | 426 |
| 2 | 2017 | 247 | |
| 3 | 2005 | 212 | |
| 4 | 2019 | 101 | |
| 5 | 2020 | 92 | |
| 6 | 2016 | 88 | |
| 7 | 2013 | 84 | |
| 8 | 2021 | 80 | |
| 9 | 2017 | 60 | |
| 10 | 2011 | 44 | |
| 11 | 2015 | 33 | |
| 12 | 2018 | 26 | |
| 13 | 2016 | 25 | |
| 14 | 2020 | 23 | |
| 15 | 2020 | 19 | |
| 16 | Epithelioid inflammatory myofibroblastic sarcoma of stomach: diagnostic pitfalls and clinical characteristics. | 2019 | 14 |
| 17 | 2020 | 10 | |
| 18 | 2015 | 8 | |
| 19 | 2017 | 8 | |
| 20 | 2020 | 6 |
About Weiwei Wu
Weiwei Wu is a scholar working on Immunology, Oncology, Epidemiology, Physiology and Molecular Biology, having authored 32 papers that have together received 1.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers), Erythrocyte Function and Pathophysiology (4 papers), Phagocytosis and Immune Regulation (4 papers), Antifungal resistance and susceptibility (3 papers), Fungal Infections and Studies (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). The work is most often cited by research in Immunology (797 citations), Oncology (710 citations), Biological Psychiatry (41 citations), Behavioral Neuroscience (33 citations) and Molecular Biology (442 citations). Weiwei Wu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Monica Manglani, Philipp A. Lang, Luca Gattinoni, Yun Ji, Pamela L. Schwartzberg, Abdel G. Elkahloun, Stacie M. Anderson, Tuoqi Wu, Dorian B. McGavern and Elizabeth Kenyon. Their work appears in journals such as Oncotarget, Molecular Cancer Therapeutics, Blood, Cancer Immunology Immunotherapy and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.